# VolulyteTM in Cardiac Surgery

> **NCT01553617** · PHASE4 · COMPLETED · sponsor: **Fresenius Kabi** · enrollment: 133 (actual)

## Conditions studied

- Heart; Dysfunction Postoperative, Cardiac Surgery

## Interventions

- **DRUG:** 6% hydroxyethyl starch 130/0.4 in an isotonic electrolyte solution (VolulyteTM)
- **DRUG:** Human serum albumin

## Key facts

- **NCT ID:** NCT01553617
- **Lead sponsor:** Fresenius Kabi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2014-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01553617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01553617, "VolulyteTM in Cardiac Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01553617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*